CSR Analysis Medincell
medincell.comDevelopment of innovative pharmaceutical and biotechnology products, focusing on advanced drug delivery systems.
Development of innovative pharmaceutical and biotechnology products, focusing on advanced drug delivery systems.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Nemera
B
Design and manufacture drug delivery device solutions for pharmaceutical, biotechnology, and generic industries.
Aptar
B
Development of consumer dispensing, drug delivery, and active material science solutions for various industries.
Sanofi
B
Development of innovative medicines and vaccines to improve patients' lives, focusing on areas like immunology, oncology, rare diseases, and vaccines.
Initiatives identified among leaders
Conception de produits et de processus pour réduire les émissions de gaz à effet de serre
“Aptar conçoit des produits et des processus pour r...” - AptarDéveloppement de produits recyclables et réduction des déchets plastiques
“Nemera s'engage dans la circularité en développant...” - NemeraRapport annuel sur les émissions de gaz à effet de serre
“Aptar publie un rapport annuel sur les émissions d...” - Aptar52% of similar organizations communicate on CSR issues
+746 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports
